🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy to share that our latest preprint is now accessible on Research Square! We explored the genetic factors influencing COVID-19 vaccine antibody response and breakthrough infection. Have a look at the main findings👇🏽👇🏽

Couldn't agree more!!

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds theguardian.com/science/2024/m…

Findings from the study that I participated in for my bachelor thesis are now published: **COVID-19 vaccination reduced risk of post-COVID cardiac and thromboembolic complications!** Immensly grateful to my supervisors Martí Català Clara Prats @prieto_alhambra and l’Annika!

Key promises of modern PGx: (1) Providing mechanistic insights into why drugs&vax are only effective or unsafe for a subset of people (2) Triangulating causal inference from RCT, RWE, to genetic evidence. See how we realise these through collaborative work in PED team.

A new study led by Junqing Xie has unveiled new insights into how our genetic makeup influences the body’s response to COVID-19 vaccines. The research may open new paths to personalised vaccination strategies. ndorms.ox.ac.uk/news/cracking-…

Discover how we're bringing real-world and patient-reported data to gain vital&novel insights into Long Covid. Our research uncovers core symptoms, subtypes, risk factors, and more. Check out our preprint 👇 and share your thoughts! @prieto_alhambra @RutgerWalls Long Covid Support 🌍

Last month, I had the opportunity to showcase our work at the OHDSI Europe Symposium with a poster on using the CohortConstructor R package to build matched cohorts. We showed how this tool can offer significant advantages for large-scale characterisation👇👇

A reminder for all of us: having a healthy lifestyle will not only build up your resilience 💪to chronic ill but also to cope with stresses, such as lingering COVID-19. Check out our latest research evidence, now featured in Nature Communications ! NDORMS MRC Epidemiology Unit Long Covid Support 🌍. 👇

Very happy to have had the opportunity to show our work on PDE-5 inhibitors and AD risk at #ISPEAnnual2024! Thank you to all the co-authors for all the guidance, and to the Health Data Sciences research group for the unwavering support!

"Genome-wide association studies of COVID-19 vaccine seroconversion and breakthrough outcomes in UK Biobank" Nature Communications NDORMS University of Oxford nature.com/articles/s4146… ABSTRACT Understanding the genetic basis of COVID-19 vaccine seroconversion is crucial to study the role of

Excited to share that our study on PDE5 inhibition and Alzheimer's disease risk is finally out as a preprint! Danielle couldn't resist dropping a cheeky spoiler, but take a look at the full publication for all the juicy details👇